| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5629021 | EXELTIS USA INC | Micellar nanoparticles |
Jan, 2015
(9 years ago) | |
Estrasorb is owned by Exeltis Usa Inc.
Estrasorb contains Estradiol Hemihydrate.
Estrasorb has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Estrasorb are:
- US5629021
Estrasorb was authorised for market use on 09 October, 2003.
Estrasorb is available in emulsion;topical dosage forms.
The generics of Estrasorb are possible to be released after 31 January, 2015.
Drugs and Companies using ESTRADIOL HEMIHYDRATE ingredient
Market Authorisation Date: 09 October, 2003
Treatment: NA
Dosage: EMULSION;TOPICAL
More Information on Dosage
ESTRASORB family patents
